About Careers Internship MedBlog Contact us
Medindia LOGIN REGISTER
Cross-Protection From Dengue and Zika Infection
Advertisement

Cross-Protection From Dengue and Zika Infection

Font : A-A+

Highlights:
  • Immune cell CD8+ T may provide cross-protection from dengue and Zika.
  • Dual infection of Zika and dengue is common.
  • Immune cell CD8+ T shows resistance to dengue and Zika virus.

Dual infection of dengue and Zika
In some parts of the world, Zika is almost like a secondary infection. It has spread to Brazil/Latin America and is moving into places in Asia where people previously had dengue.

When one encounters a pathogen in real life, two arms of the immune system spring into action to neutralize it. In the so-called humoral response, B-cells begin to secrete specific antibody proteins, which latch onto and neutralize pathogens in tissue or blood. Simultaneously, a cell-mediated immunity system also becomes active, deploying cytotoxic T-cells to directly recognize and kill pathogen-infected cells.

Advertisement


Cross-protection against dengue and Zika infection
In theory, the ideal vaccine might mimic both antibody and T cell responses to block an infectious disease. But in truth, most (26 of 28 vaccines currently licensed for human use) stimulate primarily a B-cell or antibody response, which in many cases is sufficient. But Shresta's new work confirms what many vaccinologists are beginning to suspect, namely that protection against thus far intractable pathogens will likely require rallying both B-cells and T-cells.

Specifically, Shresta's team created the first "sequential" mouse model mimicking dengue-then-Zika infection. To do that, they first infected mice genetically vulnerable to this family of viruses with dengue virus. Those mice became sick, recovered from infection, and hence acquired immunity to dengue, presumably because viral infection had mobilized their immune B-cells, T-cells or both. The group then inoculated the same mice with ZIKV and waited to see if mice showed ZIKV symptoms. But overall, mice that had previously acquired dengue immunity showed protection against Zika, as evidenced by a reduced burden of ZIKV in blood and tissues, such as brain, liver or testis, compared to control mice not "pre-inoculated" against dengue.
Advertisement

"These experiments suggest that the reason that some people infected with Zika do not come down with disease is due to prior exposure to dengue," says Shresta. "This may explain why Zika is not passed to the unborn child of every pregnant woman in dengue-endemic countries exposed to virus."

Adoptive T-cell transfer
In a different experiment, the scientists isolated cytotoxic T cells from the blood of dengue-immune mice and infused them into normal mice, a procedure known as adoptive T-cell transfer. When infused mice were then infected with ZIKV, they also showed disease resistance, supporting the idea that the T-cell arm of the immune system can do the heavy lifting against ZIKV infection.

Jinsheng Wen, Ph.D., a professor at Wenzhou Medical University in Wenzhou City, China, was the study's first author. Wen says the results from this work are a powerful lesson to vaccinologists currently wrestling with how to design an effective Zika vaccine: "Our work strongly suggests that a successful vaccine would need to include components to induce not only a B-cell response but also a T-cell response." Anti-dengue vaccines that primarily evoke antibody responses are in clinical trials or starting to be licensed in certain countries but show only moderate success. And, there are no approved Zika vaccines, although the US government is partnering with pharmaceutical companies to develop candidates.

Shresta hopes work like hers will guide those efforts. "Approved vaccines for many diseases work by inducing antibody responses. But now we are dealing with problematic diseases, like dengue and Zika for which we cannot rely solely on raising antibodies. Certain pathogens are likely to also require a T-cell response."

References :
  1. Jinsheng Wen, Annie Elong Ngono et al. Dengue Virus-Reactive CD8+ T Cells Mediate Cross-Protection Against Subsequent Zika Virus Challenge, Nature Communications doi:10.1038/s41467-017-01669-z

Citations   close

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Chrisy Ngilneii. (2017, November 14). Cross-Protection From Dengue and Zika Infection. Medindia. Retrieved on Sep 24, 2022 from https://www.medindia.net/news/healthwatch/cross-protection-from-dengue-and-zika-infection-174624-1.htm.

  • MLA

    Chrisy Ngilneii. "Cross-Protection From Dengue and Zika Infection". Medindia. Sep 24, 2022. <https://www.medindia.net/news/healthwatch/cross-protection-from-dengue-and-zika-infection-174624-1.htm>.

  • Chicago

    Chrisy Ngilneii. "Cross-Protection From Dengue and Zika Infection". Medindia. https://www.medindia.net/news/healthwatch/cross-protection-from-dengue-and-zika-infection-174624-1.htm. (accessed Sep 24, 2022).

  • Harvard

    Chrisy Ngilneii. 2021. Cross-Protection From Dengue and Zika Infection. Medindia, viewed Sep 24, 2022, https://www.medindia.net/news/healthwatch/cross-protection-from-dengue-and-zika-infection-174624-1.htm.

Advertisement

Advertisement
News A-Z
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
What's New on Medindia
Test Your Knowledge About Chromosomes?
Eating During Sunlight Hours Minimizes Mood Vulnerabilities
Know More About the Digestive System
View all
Recommended Reading
News Archive
Date
Category
Advertisement
News Category

Medindia Newsletters Subscribe to our Free Newsletters!
Terms & Conditions and Privacy Policy.

More News on:
Dengue Fever Dengue / Dengue Hemorrhagic Fever Mosquito Diseases Dengue and Homeopathy Chikungunya and Homeopathy Chikungunya Dengue Flu Top 15 Doīs and Donīts for Preventing and Managing Dengue Fever Dengue Vaccine 

Most Popular on Medindia

Indian Medical Journals Drug Side Effects Calculator Drug Interaction Checker Daily Calorie Requirements Selfie Addiction Calculator Drug - Food Interactions Color Blindness Calculator Accident and Trauma Care Noscaphene (Noscapine) Post-Nasal Drip
This site uses cookies to deliver our services. By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use
×

Cross-Protection From Dengue and Zika Infection Personalised Printable Document (PDF)

Please complete this form and we'll send you a personalised information that is requested

You may use this for your own reference or forward it to your friends.

Please use the information prudently. If you are not a medical doctor please remember to consult your healthcare provider as this information is not a substitute for professional advice.

Name *

Email Address *

Country *

Areas of Interests